| For: | Reinglas J, Gonczi L, Kurt Z, Bessissow T, Lakatos PL. Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases. World J Gastroenterol 2018; 24(32): 3567-3582 [PMID: 30166855 DOI: 10.3748/wjg.v24.i32.3567] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i32/3567.htm |
| Number | Citing Articles |
| 1 |
Noémi Mónika Szeifert, Simon Szilágyi, Barbara Sebők, Márk Bérdi. A violens öngyilkossági kísérletek számának változása a COVID–19-járvány első két évében a Dr. Manninger Jenő Baleseti Központban.. Orvosi Hetilap 2023; 164(26) doi: 10.1556/650.2023.32819
|
| 2 |
Tushar Shukla, Bruce E. Sands. Novel Non-biologic Targets for Inflammatory Bowel Disease. Current Gastroenterology Reports 2019; 21(5) doi: 10.1007/s11894-019-0689-2
|
| 3 |
De-Gao He, Xi-Jie Chen, Juan-Ni Huang, Jun-Guo Chen, Min-Yi Lv, Tian-Ze Huang, Ping Lan, Xiao-Sheng He. Increased risk of colorectal neoplasia in inflammatory bowel disease patients with post-inflammatory polyps: A systematic review and meta-analysis. World Journal of Gastrointestinal Oncology 2022; 14(1): 348-361 doi: 10.4251/wjgo.v14.i1.348
|
| 4 |
Vishal Sharma, Sandeep Thareja, Vivek Hande, Usha Dutta, Siddharth Shukla, Amit Kumar, Rinkalben Kakadiya, Kodavoor Padmaprakash, Shubham Jain, Swatantra Gupta, Anuraag Jena, Pradeep K Singh, Aditya V Pachisia, Sumit Bhatia, Akshay Kulkarni, Kiran Peddi, Kartik Natarajan, Philip Augustine, Rizwan Ahamed, Rajat Shukla, Ajay Shankar Prasad, Sonal Singh, Anoop K Koshy, Priya Nair, Shubhra Mishra, Arun Valsan, Shilpa Prasad, Daya Krishna Jha. Latent tuberculosis screening for inflammatory bowel disease in tuberculosis endemic region remains porous and suboptimal: A multicentre study. World Journal of Gastroenterology 2026; 32(4): 114897 doi: 10.3748/wjg.v32.i4.114897
Abstract(88) |
Core Tip(82) |
Full Article(HTML)(587)
|
Full Article (PDF)-474K(377)
|
Full Article with Cover (PDF)-771K(156)
|
Full Article (XML)-121K(42)
|
Audio-1893K(10)
|
Peer-Review Report-290K(35)
|
Answering Reviewers-260K(83)
|
Supplementary Material-155K(37)
|
Times Cited (1)
|
Total Visits (1219)
|
Open
|
| 5 |
F. Lusetti, C. Bezzio, A. De Bernardi, M. Dota, G. Manes, S. Saibeni. The TL1A inhibitors in IBD: what’s in the pot?. Expert Review of Gastroenterology & Hepatology 2025; 19(1) doi: 10.1080/17474124.2025.2450795
|
| 6 |
A. A. Kamanin, D. G. Nomokonov, R. V. Cheminava, V. P. Morozov. Actual methods of treatment of parar ectal fistulas in Crohn’s disease. Grekov's Bulletin of Surgery 2025; 184(4) doi: 10.24884/0042-4625-2025-184-4-102-109
|
| 7 |
Nicole L. Mancini, Luke Goudie, Warren Xu, Rasha Sabouny, Sruthi Rajeev, Arthur Wang, Nicolas Esquerre, Ala Al Rajabi, Timothy S. Jayme, Erik van Tilburg Bernandes, Yasmin Nasser, José G.P. Ferraz, Timothy Shutt, Jane Shearer, Derek M. McKay. Perturbed Mitochondrial Dynamics Is a Novel Feature of Colitis That Can Be Targeted to Lessen Disease. Cellular and Molecular Gastroenterology and Hepatology 2020; 10(2) doi: 10.1016/j.jcmgh.2020.04.004
|
| 8 |
Cindy CY Law, Conor Bell, Deborah Koh, Yueyang Bao, Vipul Jairath, Neeraj Narula. Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease. Cochrane Database of Systematic Reviews 2020; 2021(12) doi: 10.1002/14651858.CD013256.pub2
|
| 9 |
Ivanna Candel, Panu Wetwittayakhlang, Talat Bessissow, Peter L. Lakatos. The Importance of Post-Inflammatory Polyps (PIPs) in Colorectal Cancer Surveillance in Inflammatory Bowel Diseases. Journal of Clinical Medicine 2025; 14(2) doi: 10.3390/jcm14020333
|
| 10 |
Wenjuan Liu, Zirong Dong, Kaiheng Liu, Yi Lu, Wei Wu, Jianping Qi, Zhongjian Chen. Targeting strategies of oral nano-delivery systems for treating inflammatory bowel disease. International Journal of Pharmaceutics 2021; 600 doi: 10.1016/j.ijpharm.2021.120461
|
| 11 |
Yago González-Lama, Elena Ricart, Daniel Carpio, Guillermo Bastida, Daniel Ceballos, Daniel Ginard, Ignacio Marin-Jimenez, Luis Menchen, Fernando Muñoz. Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus. BMJ Open Gastroenterology 2024; 11(1) doi: 10.1136/bmjgast-2023-001246
|
| 12 |
Sara Salvador-Martín, Beatriz López-Cauce, Olga Nuñez, Emilio J. Laserna-Mendieta, María I. García, Elena Lobato, Judith Abarca-Zabalía, María Sanjurjo-Saez, Alfredo J. Lucendo, Ignacio Marín-Jiménez, Luis A. Menchén, Luis A. López-Fernández. Genetic predictors of long-term response and trough levels of infliximab in crohn’s disease. Pharmacological Research 2019; 149 doi: 10.1016/j.phrs.2019.104478
|
| 13 |
Nikita Desai, Tarun Kaura, Maharaj Singh, Field F. Willingham, Surinder Rana, Saurabh Chawla. Epidemiology and Characteristics of Chronic Pancreatitis—Do the East and West Meet?. Gastro Hep Advances 2022; 1(6) doi: 10.1016/j.gastha.2022.07.013
|
| 14 |
Balaji Venkataraman, Shreesh Ojha, Prasanna D. Belur, Bhoomendra Bhongade, Vishnu Raj, Peter D. Collin, Thomas E. Adrian, Sandeep B. Subramanya. Phytochemical drug candidates for the modulation of peroxisome proliferator‐activated receptor γ in inflammatory bowel diseases. Phytotherapy Research 2020; 34(7) doi: 10.1002/ptr.6625
|
| 15 |
Stuart Bloom, Tariq Iqbal, Chuka Nwokolo, Vipul Jairath, Jesse Hall, Bruce Dzyngel, Peter Gardzinski. 713 A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of a Targeted Release Oral Cyclosporine Formulation in the Treatment of Mild to Moderate Ulcerative Colitis: Influence of Immunosuppressants at Baseline. American Journal of Gastroenterology 2019; 114(1) doi: 10.14309/01.ajg.0000592388.53875.b2
|
| 16 |
Oliberto Sánchez Ramos. Development and Validation of a Phenomenological Model for Scalable Size-Exclusion Chromatography in TNF-Blocking Peptide Purification. BioNatura Journal: Ibero-American Journal of Biotechnology and Life Sciences 2025; 2(2) doi: 10.70099/BJ/2025.02.02.2
|
| 17 |
Cindy CY Law, Deborah Koh, Yueyang Bao, Vipul Jairath, Neeraj Narula. Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease. Cochrane Database of Systematic Reviews 2019; doi: 10.1002/14651858.CD013256
|
| 18 |
Yan Xu, Aditi Sharma, Yang Chen, Honghui Zhou. What We Can Learn from Current Inflammatory Bowel Disease (IBD) Biological Therapy—Dose Regimen and Others. Current Pharmacology Reports 2019; 5(3) doi: 10.1007/s40495-019-00180-x
|
| 19 |
Jing-Wei Mao. Small molecule agents in clinical management of inflammatory bowel disease: Current status and future prospects. World Chinese Journal of Digestology 2023; 31(22) doi: 10.11569/wcjd.v31.i22.913
Abstract(692) |
Core Tip(796) |
Full Article(HTML)(4989)
|
Times Cited (0)
|
Total Visits (5731)
|
Open
|
| 20 |
Yan Xu, Chuanpu Hu, Yang Chen, Xin Miao, Omoniyi J. Adedokun, Zhenhua Xu, Amarnath Sharma, Honghui Zhou. Population Pharmacokinetics and Exposure‐Response Modeling Analyses of Ustekinumab in Adults With Moderately to Severely Active Ulcerative Colitis. The Journal of Clinical Pharmacology 2020; 60(7) doi: 10.1002/jcph.1582
|
| 21 |
Padhmanand Sudhakar, Dahham Alsoud, Judith Wellens, Sare Verstockt, Kaline Arnauts, Bram Verstockt, Severine Vermeire. Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All. Journal of Crohn's and Colitis 2022; 16(8) doi: 10.1093/ecco-jcc/jjac027
|
| 22 |
Nagesh Kamat, Gaurav Patil, Ankit Dalal, Sanil Parekh, Amit Maydeo. Affordability issues and the need for a reimbursement process of advanced therapy for inflammatory bowel diseases in India. Current Medical Research and Opinion 2025; 41(6) doi: 10.1080/03007995.2025.2534471
|
| 23 |
Michel Adamina, Stefanos Bonovas, Tim Raine, Antonino Spinelli, Janindra Warusavitarne, Alessandro Armuzzi, Oliver Bachmann, Palle Bager, Livia Biancone, Bernd Bokemeyer, Peter Bossuyt, Johan Burisch, Paul Collins, Glen Doherty, Alaa El-Hussuna, Pierre Ellul, Gionata Fiorino, Cornelia Frei-Lanter, Federica Furfaro, Christian Gingert, Paolo Gionchetti, Javier P Gisbert, Fernando Gomollon, Marien González Lorenzo, Hannah Gordon, Tibor Hlavaty, Pascal Juillerat, Konstantinos Katsanos, Uri Kopylov, Eduards Krustins, Torsten Kucharzik, Theodore Lytras, Christian Maaser, Fernando Magro, John Kenneth Marshall, Pär Myrelid, Gianluca Pellino, Isadora Rosa, Joao Sabino, Edoardo Savarino, Laurents Stassen, Joana Torres, Mathieu Uzzan, Stephan Vavricka, Bram Verstockt, Oded Zmora. ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment. Journal of Crohn's and Colitis 2020; 14(2) doi: 10.1093/ecco-jcc/jjz187
|
| 24 |
Sophie Restellini, Waqqas Afif. Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease. Journal of Clinical Medicine 2021; 10(6) doi: 10.3390/jcm10061242
|
| 25 |
Bob Geng, Timothy J. Craig. Small molecule drugs for atopic dermatitis, rheumatoid arthritis, and hereditary angioedema. Annals of Allergy, Asthma & Immunology 2022; 128(3) doi: 10.1016/j.anai.2021.10.015
|
| 26 |
Irene Marafini, Silvia Sedda, Vincenzo Dinallo, Giovanni Monteleone. Inflammatory cytokines: from discoveries to therapies in IBD. Expert Opinion on Biological Therapy 2019; 19(11) doi: 10.1080/14712598.2019.1652267
|
| 27 |
Peter Kienle. Impact of Modern Drug Therapy on Surgery: Crohn's Disease. Visceral Medicine 2018; 34(6) doi: 10.1159/000495127
|
| 28 |
Rachel Rutherford, Patrick B Allen. New and Old Therapeutic Options for Luminal Crohn's Disease - An Overview of Current Literature. OBM Hepatology and Gastroenterology 2019; 3(03) doi: 10.21926/obm.hg.1903031
|
| 29 |
Boris Gole, Uroš Potočnik. Pre-Treatment Biomarkers of Anti-Tumour Necrosis Factor Therapy Response in Crohn’s Disease—A Systematic Review and Gene Ontology Analysis. Cells 2019; 8(6) doi: 10.3390/cells8060515
|
| 30 |
Ciro Romano, Sergio Esposito, Roberta Ferrara, Giovanna Cuomo. Choosing the most appropriate biologic therapy for Crohn’s disease according to concomitant extra-intestinal manifestations, comorbidities, or physiologic conditions. Expert Opinion on Biological Therapy 2020; 20(1) doi: 10.1080/14712598.2020.1689953
|
| 31 |
Elena Milanesi, Maria Dobre, Teodora E. Manuc, Gabriel Becheanu, Cristian G. Tieranu, Elena M. Ionescu, Mircea Manuc. Mucosal gene expression changes induced by anti‐TNF treatment in inflammatory bowel disease patients. Drug Development Research 2019; 80(6) doi: 10.1002/ddr.21566
|
| 32 |
Maria Chiara Ditto, Simone Parisi, Gianpiero Landolfi, Richard Borrelli, Cristina Realmuto, Annacarla Finucci, Gian Paolo Caviglia, Davide Giuseppe Ribaldone, Marco Astegiano, Anna Zanetti, Greta Carrara, Carlo Alberto Scirè, Marco Antivalle, Piercarlo Sarzi-Puttini, Enrico Fusaro. Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis. RMD Open 2021; 7(3) doi: 10.1136/rmdopen-2021-001755
|
| 33 |
Jianping Zhou, Yuting Xi, Ting Wu, Xiaoyu Zeng, Jun Yuan, Lei Peng, Hao Fu, Ce Zhou. A potential therapeutic approach for ulcerative colitis: targeted regulation of mitochondrial dynamics and mitophagy through phytochemicals. Frontiers in Immunology 2025; 15 doi: 10.3389/fimmu.2024.1506292
|
| 34 |
Jörg D. Schulzke, Michael Fromm. Ion Transport Across Epithelial Tissues and Disease. Physiology in Health and Disease 2020; doi: 10.1007/978-3-030-55310-4_3
|
| 35 |
Michel Adamina, Gionata Fiorino. At the Crossroads of Caution and Intervention: Anti-TNF Therapy Prior to Elective CD Surgery. Journal of Crohn's and Colitis 2021; 15(10) doi: 10.1093/ecco-jcc/jjab092
|
| 36 |
Cecilia Dell’Avalle, Ferdinando D’Amico, Roberto Gabbiadini, Arianna Dal Buono, Nicola Pugliese, Alessandra Zilli, Federica Furfaro, Gionata Fiorino, Mariangela Allocca, Laurent Peyrin-Biroulet, Silvio Danese. JAK inhibitors in crohn’s disease: ready to go?. Expert Opinion on Investigational Drugs 2022; 31(2) doi: 10.1080/13543784.2022.2032639
|
| 37 |
Javier Plaza, Alejandro Mínguez, Guillermo Bastida, Remedios Marqués, Pilar Nos, Jose Luis Poveda, Inés Moret-Tatay. Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review. International Journal of Molecular Sciences 2024; 25(7) doi: 10.3390/ijms25073717
|
| 38 |
Cynthia Morvillo, Katherine Vinci, Lauren Hedenschoug, Leah Mancini, Carrie Mize, Kayce Tugg, Steven Stein. Risks and Safety of Advanced Therapies and Biologics in Inflammatory Bowel Disease. Gastroenterology Nursing 2020; 43(4) doi: 10.1097/SGA.0000000000000523
|
| 39 |
Edvin Brusač, Mario-Livio Jeličić, Daniela Amidžić Klarić, Biljana Nigović, Nikša Turk, Ilija Klarić, Ana Mornar. Pharmacokinetic Profiling and Simultaneous Determination of Thiopurine Immunosuppressants and Folic Acid by Chromatographic Methods. Molecules 2019; 24(19) doi: 10.3390/molecules24193469
|
| 40 |
Michel Adamina, Silvia Minozzi, Janindra Warusavitarne, Christianne Johanna Buskens, Maria Chaparro, Bram Verstockt, Uri Kopylov, Henit Yanai, Stephan R Vavricka, Rotem Sigall-Boneh, Giuseppe S Sica, Catherine Reenaers, Georgios Peros, Konstantinos Papamichael, Nurulamin Noor, Gordon William Moran, Christian Maaser, Gaetano Luglio, Paulo Gustavo Kotze, Taku Kobayashi, Konstantinos Karmiris, Christina Kapizioni, Nusrat Iqbal, Marietta Iacucci, Stefan Holubar, Jurij Hanzel, João Guedelha Sabino, Javier P Gisbert, Gionata Fiorino, Catarina Fidalgo, Pierre Ellu, Alaa El-Hussuna, Joline de Groof, Wladyslawa Czuber-Dochan, María José Casanova, Johan Burisch, Steven Ross Brown, Gabriele Bislenghi, Dominik Bettenworth, Robert Battat, Raja Atreya, Mariangela Allocca, Manasi Agrawal, Tim Raine, Hannah Gordon, Pär Myrelid. ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment. Journal of Crohn's and Colitis 2024; 18(10) doi: 10.1093/ecco-jcc/jjae089
|
| 41 |
Sumaiah J. Alarfaj, Sally Abdallah Mostafa, Walaa A. Negm, Thanaa A. El-Masry, Marwa Kamal, Mohamed Elsaeed, Ahmed Mohamed El Nakib. Mucosal Genes Expression in Inflammatory Bowel Disease Patients: New Insights. Pharmaceuticals 2023; 16(2) doi: 10.3390/ph16020324
|
| 42 |
Simon P. Borg-Bartolo, Ray Kiran Boyapati, Jack Satsangi, Rahul Kalla. Precision medicine in inflammatory bowel disease: concept, progress and challenges. F1000Research 2020; 9 doi: 10.12688/f1000research.20928.1
|
| 43 |
Young-Jae Hwang, Seung-Joo Nam, Wanjoo Chun, Song In Kim, Sung Chul Park, Chang Don Kang, Sung Joon Lee, Partha Mukhopadhyay. Anti-inflammatory effects of apocynin on dextran sulfate sodium-induced mouse colitis model. PLOS ONE 2019; 14(5) doi: 10.1371/journal.pone.0217642
|